Login

Financial Snapshot

Revenue
TTM
$3.329M
Gross Margin
TTM
85.17%
Net Income
TTM
-$26.00M
Current Assets
2025 Q3
Current Liabilities
2025 Q3
Current Ratio
2025 Q3
297.98%
Total Assets
2025 Q3
Total Liabilities
2025 Q3
Book Value
2025 Q3
-53.95M
Cash
2025 Q3
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$16.27M

Stock Price

Loading...
Market Cap: $1.68 Million

About Clearside Biomedical, Inc

The filing excerpts provided for CLSDQ (accession 000095017025046134, filed 2025-03-27) contain only boilerplate SEC cover-page text and do not include any substantive business description, financial data, segment information, or operational details sufficient to construct a grounded company summary.

Source: SEC 10-K, filed 2025-03-27

Industry: Pharmaceutical Preparations Peers: TherapeuticsMD Inc Anebulo Pharmaceuticals Inc Aquestive Therapeutics Inc Hyperion DeFi Inc Johnson & Johnson Longboard Pharmaceuticals, Inc. Medicine Man Technologies, Inc. SCYNEXIS Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support